Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
||
3034.0: Monday, December 12, 2005: 8:30 AM-10:00 AM | |||
Oral | |||
| |||
This session highlights some of the patterns and characteristics of public-private partnerships (PPPs) in the health sector, primarily citing examples in developing countries. Different aspects of PPPs, from actual health care provision to public health endeavors, will be covered in this session. Specifically, the presentations will discuss (1) results of a report “Priority Medicines for Europe and the World” presented to the EU by the WHO, citing public-private partnerships as an important vehicle to developing medicines for which there is minimal commercial incentive; (2) use of a district level stakeholder secretariat in Kenya to facilitate joint planning and implementation of work plans, as well as strengthen relationships between partners and with the Ministry of Health; (3) the impact of a public-private partnership in Mexico to provide “youth-friendly” pharmaceutical and reproductive health services and (4) utilization and expenditure patterns in rural Bangladesh to evaluate the role of public and private sector, and the health policy implications of the public-private mix. | |||
Learning Objectives: At the conclusion of the session, the participant will be able to (1) develop an understanding of public-private partnerships (PPPs) in health care provision in developing countries and (2) assess different strategies in incorporating the private sector into public health objectives. | |||
Beth E. Rivin, MD, MPH | |||
Introductory Remarks | |||
Public-Private Partnerships for neglected diseases: Opportunities for the European Union to address pharmaceutical gaps for neglected diseases Elizabeth Ziemba, JD, MPH | |||
Networking For Sustainable Health Laban Tsuma, MD, MPH, Eileen Wilson | |||
Public-private collaboration to create youth friendly pharmacies for reproductive health services in Mexico: Impact and implications for replication and scale up Kelly J. Wolfe, MEd, Ruth Berg, PhD | |||
Concluding Remarks | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | International Health | ||
Endorsed by: | Public Health Education and Health Promotion; Public Health Nursing | ||
CE Credits: | CME, Health Education (CHES), Nursing |
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA